Nanoform Finland

0.50 EUR

+4.63%

3,710 following

NANOFH

First North Finland

Medical Equipment & Services

Health Care

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Nanoform Finland

2019202020212022202320242025
Revenue0.56.920.039.028.631.938.3
growth-%1,250.7 %188.9 %94.7 %-26.6 %11.4 %20.4 %
EBITDA-72.3-183.6-181.9-212.5-218.2-241.0-164.6
EBIT-76.9-196.0-202.0-239.2-250.3-278.0-199.6
Profit before taxes-79.1-196.1-201.8-246.4-230.8-268.4-193.0
Net income-79.1-196.2-201.8-246.6-231.1-268.7-193.4
EPS-1.19-2.95-3.03-3.24-2.89-3.21-2.27
Dividend0.000.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%-14,081.6 %-2,648.8 %-908.1 %-545.2 %-762.6 %-756.5 %-429.3 %
EBIT-%-14,987.8 %-2,827.2 %-1,008.4 %-613.5 %-874.7 %-872.4 %-520.6 %
ROE-95.2 %-31.0 %-23.3 %-25.3 %-31.0 %-39.0 %-41.8 %
ROI-58.5 %-26.3 %-19.8 %-21.9 %-26.6 %-32.6 %-33.2 %